Incont L.A. 30 Tablets

Incont L.A. 30 Tablets

Description:

Incont L.A. 30 Tablets is a prescription oral medicine containing tolterodine l-tartrate 4 mg, manufactured by Adwia. It belongs to the anticholinergic (antimuscarinic) class and is specifically formulated for the long-acting control of overactive bladder and urinary incontinence. By selectively blocking muscarinic (M3) receptors in the bladder wall, Incont L.A. helps relax the detrusor muscle, increase bladder capacity, and reduce involuntary bladder contractions, thereby decreasing urinary frequency, urgency, and episodes of urge incontinence. It is intended for adult patients under medical supervision as part of urinary tract and bladder disorder management.

Indications:

• Treatment of symptoms of overactive bladder, including increased urinary frequency.
• Management of urinary urgency (sudden, strong need to urinate).
• Reduction of urge urinary incontinence (involuntary leakage of urine associated with urgency).
• Supportive treatment in patients with unstable bladder or detrusor overactivity, as diagnosed by a physician.

Active Ingredients / Key Components:

• Tolterodine l-tartrate – 4 mg per tablet (anticholinergic / antimuscarinic agent).
• Excipients: Information on inactive ingredients (e.g., fillers, binders, colorants, preservatives) is not available in the provided data. Please refer to the official package insert for a complete excipient list.

Dosage & Administration / How to Use:

• Usual adult dose (as commonly used for tolterodine l-tartrate prolonged-release 4 mg): 1 tablet (4 mg) once daily, or as directed by your physician.
• Swallow the tablet whole with a sufficient amount of water. Do not crush, chew, or break the tablet, as this may affect the long-acting (L.A.) release profile.
• Can be taken with or without food, preferably at the same time each day to maintain consistent blood levels.
• Use only under medical supervision. Your doctor may adjust the dose based on your response, kidney function, liver function, and tolerability.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed tablet.
• Do not stop treatment abruptly without consulting your doctor, as symptoms of overactive bladder may return.

Clinical Benefits:

• Helps control symptoms of overactive bladder by reducing involuntary bladder contractions.
• Decreases urinary frequency and urgency, improving bladder control and comfort.
• Reduces episodes of urge urinary incontinence, helping to minimize accidental urine leakage.
• Increases functional bladder capacity, allowing longer intervals between urination.
• Supports better quality of life, social confidence, and daily activity participation for patients with urinary incontinence.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to tolterodine l-tartrate or any component of the formulation.
• Contraindicated in patients with urinary retention, uncontrolled narrow-angle glaucoma, or severe gastrointestinal conditions such as toxic megacolon.
• Use with caution in patients with impaired liver function or kidney function; dose adjustment may be required.
• Use with caution in patients with bladder outlet obstruction, gastrointestinal obstructive disorders, decreased gastrointestinal motility, or autonomic neuropathy.
• May cause blurred vision, dizziness, or drowsiness; avoid driving or operating machinery if affected.
• Consult your doctor before use if pregnant or planning pregnancy. Use during pregnancy only if clearly needed and prescribed by a physician.
• Consult your doctor before use if breastfeeding; it is not known to what extent tolterodine passes into breast milk. A risk–benefit assessment is required.
• Inform your doctor about all medications you are taking, especially other anticholinergics, antifungals (e.g., ketoconazole), macrolide antibiotics, or medications affecting liver enzymes, as interactions may occur.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical evaluation and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects: dry mouth, constipation, headache, dry eyes, dyspepsia (indigestion), abdominal discomfort, and dizziness.
• Other possible effects: blurred vision, urinary retention or difficulty urinating, fatigue, and palpitations.
• Serious side effects (seek immediate medical attention): severe allergic reactions (rash, itching, swelling of face or tongue, difficulty breathing), severe urinary retention, severe abdominal pain, confusion, or rapid heartbeat.
• If any side effects persist, worsen, or you notice any unusual symptoms, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date stated on the packaging. Store at or below the temperature specified on the pack (exact temperature information is not available in the provided data; refer to the original package insert).

Specifications:

• Product type: Prescription medicine for overactive bladder and urinary incontinence.
• Active ingredient strength: tolterodine l-tartrate 4 mg per tablet.
• Form: Oral tablet, long-acting (L.A.).
• Pack size: 30 tablets per pack.
• Intended use: Adult patients as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.